Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Sorafenib_Resminostat

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Sorafenib_Resminostat BRAF, KDR, FLT4, PDGFRB, KIT, FLT3, RET and HDAC1/3/6 Drug combination Selleck Chemicals S1040, S2693

Cell Line (34)
Cell LineAUCGI50
B10.680.7
JHH50.690.88
Li70.70.728
JHH70.711.074
SNU3540.730.515
Huh60.781.66
SNU7610.83.05
JHH10.81.1
HCC.1.20.813.55
SNU7390.812.881
HLE0.812.7
Huh10.833.452
Huh70.833.0
SNU4230.843.371
HLF0.843.843


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it